Wen Mingyun currently serves as the Technical Director of Beverly Plastic Surgery. He has been engaged in the plastic and aesthetic industry for more than 20 years, including more than 10 years of clinical work in plastic and aesthetic surgery in hospitals. He has accumulated experience with more than 20,000 plastic surgery cases and has had no failed cases to date. His refined and superb techniques have earned him high attainments in the industry and high recognition from plastic surgery professionals at home and abroad. Director Wen’s signature procedures include eye plastic surgery, especially his Lingyun Fine Sculpture Eye Enlargement Surgery, which is one of the procedures with the best patient feedback. Another procedure with high satisfaction is rib cartilage rhinoplasty. He is also an expert advocate of autologous tissue rhinoplasty and has particularly made original achievements in facial, breast, and failed surgery revision fields. He is skilled at providing beauty seekers with personalized treatment plans that combine fashion and classic elements, and is hailed by the industry as “Expert in Fine Personalized Contouring.”

 

He studied under Dr. Liu Dalie, Professor Li Zhanqiang, and Professor Niu Yonggan, leading authorities in medical plastic surgery. Under the guidance and influence of these masters, he has conducted years of research on facial feature plastic surgery and developed his own unique surgical style and techniques. Over the decades, he has been invited many times to attend plastic and aesthetic surgery academic exchange conferences between China and South Korea, China and Japan, and China and the United States, among others. In China, he enjoys reputations such as “King of Chinese Contouring” and “King of Beautiful Noses in Fujian.”

 

Special Contributor to Journal of Practical Aesthetic Surgery

Invited Training Expert for Botox Injection Techniques

 

Lingyun Fine Sculpture Eye Enlargement Surgery, implant breast augmentation, rib cartilage rhinoplasty, injectable aesthetic treatments, etc.